Tiger Aesthetics Medical, LLC, has bought select assets from Suneva Medical, Inc. including BellaFill biostimulatory dermal filler, Silhouette Instalift and Amplifine PRP.
These additional products and assets further strengthen Tiger Aesthetics’ market presence in regenerative aesthetics and complements the company’s upcoming adipose cell and tissue products, alloClae and dermaClae.
“With this acquisition, we continue to bring together unique clinical applications and revenue streams that help our customers grow their practices,” says Oliver Burckhardt, Co-CEO of Tiger BioSciences, in a news release. “The addition of these products marks a significant step toward our goal of becoming a leader in both facial and full body aesthetics.”
“All across the world, there is growing demand for regenerative treatments that deliver natural and impactful results,” adds Pat Altavilla, CEO of Suneva Medical. “Through the acquisition of Suneva Medical assets, Tiger Aesthetics will be able to offer an even larger portfolio of products, partner with more cosmetic providers, and bring Suneva Medical’s expertise in commercializing market defining products to strategic regions globally.”
